Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
International Journal of Obesity, 2022Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study
Maalmi H., Herder C., Huth C. et al.
Olink Target 96
Biomedicines, 2022Cerebrospinal Fluid in Classical Trigeminal Neuralgia: An Exploratory Study on Candidate Biomarkers
Svedung Wettervik T., Folkvaljon D., Gordh T. et al.
Research and Practice in Thrombosis and Haemostasis, 2022Proteomics in thrombosis research
Edfors F., Iglesias M., Butler L. et al.
Expert Review of Proteomics, 2022Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications
Dayon L., Cominetti O., Affolter M.
The American Journal of Pathology, 2022Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
Price D., Benedetti E., Hoffman K. et al.
Translational Neurodegeneration, 2022Advances in the development of new biomarkers for Alzheimer’s disease
Klyucherev T., Olszewski P., Shalimova A. et al.
BJS Open, 2022Preoperative biomarkers related to inflammation may identify high-risk anastomoses in colorectal cancer surgery: explorative study
Holmgren K., Jonsson P., Lundin C. et al.
European Stroke Journal, 2022A novel biomarker panel index improves risk stratification after ischemic stroke
Bicvic A., Scherrer N., Schweizer J. et al.
Cell Reports, 2022Systems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria
Lautenbach M., Yman V., Silva C. et al.
International Journal of Rheumatic Diseases, 2022Sex differences in circulating proteins of patients with rheumatoid arthritis: A cohort study
Ferreira M., Fonseca T., Costa R. et al.
Journal for ImmunoTherapy of Cancer, 2022Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa
Tsai Y., Strauss J., Toney N. et al.
Communications Biology, 2022Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
Svensson Akusjärvi S., Krishnan S., Jütte B. et al.
Scientific Reports, 2022Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90
Heath L., Earls J., Magis A. et al.
Nature Communications, 2022Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia
Huuhtanen J., Bhattacharya D., Lönnberg T. et al.
npj Biofilms and Microbiomes, 2022Assessing the inflammatory response to in vitro polymicrobial wound biofilms in a skin epidermis model
Brown J., Townsend E., Short R. et al.
Circulation, 2022Genetic Landscape of the ACE2 Coronavirus Receptor
Yang Z., Macdonald-Dunlop E., Chen J. et al.
Vasa, 2022Novel cardiovascular biomarkers associated with peripheral arterial disease in men screened for abdominal aortic aneurysm
Dakhel A., Memon A., Zarrouk M. et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022Proteomics approaches to characterize the immune responses in cancer
Urbiola-Salvador V., Miroszewska D., Jabłońska A. et al.
Nature Communications, 2022Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer
Minas T., Candia J., Dorsey T. et al.
Cancers, 2022Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer
Gyllensten U., Hedlund-Lindberg J., Svensson J. et al.
Olink Explore 3072/384
3874 publications
Items per page
3001-3020 of 3874 publications